HST Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 29, 2022 at 11:49 am EDT
Share
HST Global, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.038214 million compared to USD 0.03874 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
